Henry Schein Profile

171.26
0.01  0.01%
Last 1 Month(s)
171174   
Trading Day 
170172   

Exercise or conversion by Paul Rose of 5394 shares of Henry Schein subject to Rule 16b3

Henry Schein Inc insider trading alert for exercise of stock option right to buy by Paul Rose, SVP Global Supply Chain, on March 26, 2017. This event was filed by Henry Schein Inc with SEC on 2017-02-23. Statement of changes in beneficial ownership - SEC Form 4. Paul Rose is currently serves as senior vice president global supply chain of Henry Schein [view details]   

Henry Schein Summary

Henry Schein Inc (HSIC) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 19,000 people. Henry Schein is listed under Wholesale category by Fama And French industry classification and specializes in Healthcare with concentration in Healthcare Products. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.97 B. Henry Schein Inc conducts business under Healthcare sector and is part of Healthcare Products industry. This company has 86.98 M outstanding shares of which 3.76 M shares are currently shorted by private and institutional investors with about 3.19 trading days to cover. HENRY SCHEIN INC currently holds about 200.65 M in cash with 134.67 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.95.
Check Henry Schein Probability Of Bankruptcy

Selected Henry Schein Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Henry Schein Against Markets

Henry Schein Leadership

Lonnie Shoff President and CEO of Global Animal Health and Strategic Partnerships Group
James Breslawski President, Executive Director and CEO of Global Dental Group
More Executives

Henry Schein Diversification Suggestion

Use Henry Schein to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Henry Schein to be traded at 179.82 in 30 days
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 9% 
Henry Schein, Inc. offer health care solutions and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. more
Fama & French Wholesale
Wholesale
Fama & French Classification
NameHenry Schein Inc
Specialization
Healthcare, Healthcare Products
InstrumentUSA Stock
RegionNorth America
LocationNEW YORK, U.S.A
Business Address135 Duryea Road, Melville, NY 11747, United States
Foreign Associate  UK
ExchangeNASDAQ
CIK Number01000228.0
ISINUS8064071025
CUSIP806407102
SectorHealthcare
MarketHealthcare Products
BenchmarkNYSE
Websitewww.henryschein.com
Contact Number631 843 5500
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Recommendations
Henry Schein Analyst Recommendations
Target PriceAdvice# of Analysts
177.14Buy7Odds
Henry Schein Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Henry Schein Analyst Advice  
Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  
Earnings
Henry Schein Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.66May 2, 2017
Henry Schein Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate